The burgeoning landscape of novel treatments for body management has seen the rise of both retatrutide and tirzepatide, both dual mechanism agonists targeting the GLP-1 and GIP receptors. While sharing a similar https://tiffanymxfz482036.wikifordummies.com/9198919/retatrutide_vs_tirzepatide_a_comparative_analysis